Prekallikrein activator and kallikrein in acetone- and kaolin-activated rat plasma.

Activation of plasminogen-free rat citrated plasma (RCPL-P) with acetone/kaolin yielded BAEe-esterase activities of 0.6--0.8 U/ml. Gel filtration demonstrated one single peak of BAEe-esterase activity (mol. wt. approximately 135000) with a kininogenase-esterase ratio (3.3) close to that known for human plasma kallikrein (2.7). Similarly activated rat citrated plasma (RCPL) revealed on gel filtration an additional esterase peak (mol. wt, approximately 47,000) with a low kininogenase-esterase ratio (0.3), and should accordingly not be used for a BAEe-esterase assay of rat plasma kallikrein. Acetone activation of RCPL-P and of RCPL yielded prekallikrein activator (PKA) activities which were about doubled by treatment with kaolin to 1.9--2.1 and 3.5--4.2 PKA-U/ml respectively. Gel filtration of acetone-activated RCPL-P or RCPL revealed two peaks of PKA activity, mol. wt. approximately 110,000 corresponding to activated factor XII (XIIa), and mol. wt. approximately 33,000 corresponding to XII fragments (XIIf). Kaolin-treatment of acetone-activated RCPL-P, but not of RCPL, caused an extensive fragmentation of XIIa to the 4--6 times more active XIIf. The lower yield of PKA-activity in acetone/kaolin-activated RCPL-P, as compared with activated RCPL, seems to be due to the absence of a factor of significance for the activation of factor XII, which is not plasmin, plasma kallikrein, or high molecular weight kininogen.

[1]  J. Berstad,et al.  Dextran-induced lowering of parameters of the kallikrein-kinin system in rat plasma: significance of monoamine-depleting agents. , 2009, Acta pharmacologica et toxicologica.

[2]  K. Briseid,et al.  Dextran-induced lowering of parameters of the kallikrein-kinin system in rat plasma. , 1979, Advances in Experimental Medicine and Biology.

[3]  E. Toverud,et al.  Dextran-induced lowering of prekallikrein proactivator and prekallikrein in rat plasma. , 2009, Acta pharmacologica et toxicologica.

[4]  P. Cuatrecasas,et al.  A simplified method for cyanogen bromide activation of agarose for affinity chromatography. , 1974, Analytical biochemistry.

[5]  K. Laake,et al.  Cold-promoted activation of factor VII in human plasma: studies on the associated acyl-arginine esterase activity. , 1974, Thrombosis research.

[6]  F. C. Arntzen,et al.  Inhibition of carrageenin-induced rat paw oedema by catecholamines and amine-depleting drugs. , 2009, Acta pharmacologica et toxicologica.

[7]  K. Wuepper,et al.  ACTIVATION OF HAGEMAN FACTOR IN SOLID AND FLUID PHASES , 1973, The Journal of experimental medicine.

[8]  K. Laake,et al.  Determination of factor XII in human plasma with arginine proesterase (prekallikrein) II. Studies on the method , 1973 .

[9]  K. Laake,et al.  Determination of factor XII in human plasma with arginine proesterase (prekallikrein) I. Preparation and properties of the substrate , 1973 .

[10]  H. Movat,et al.  The Kinin System of Human Plasma VI. The Action of Plasmin 1 , 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[11]  K. Wuepper,et al.  THE FIRST COMPONENT OF THE KININ-FORMING SYSTEM IN HUMAN AND RABBIT PLASMA , 1971, The Journal of experimental medicine.

[12]  K. Austen,et al.  A PREALBUMIN ACTIVATOR OF PREKALLIKREIN , 1971, The Journal of experimental medicine.

[13]  D. Deutsch,et al.  Plasminogen: Purification from Human Plasma by Affinity Chromatography , 1970, Science.

[14]  Kaplan Ap,et al.  A pre-albumin activator of prekallikrein. , 1970, Journal of immunology.

[15]  C. Jacobsen THE CASEINOLYTIC METHOD FOR DETERMINATION OF PLASMINOGEN-PLASMIN IN HUMAN PLASMA AND SERUM. , 1964, Scandinavian journal of clinical and laboratory investigation.